Search Login Register

Septo-Optic Dysplasia Summary

Description: A condition resulting from congenital malformations involving the brain. The syndrome of septo-optic dysplasia combines hypoplasia or agenesis of the SEPTUM PELLUCIDUM and the OPTIC NERVE. The extent of the abnormalities can vary. Septo-optic dysplasia is often associated with abnormalities of the hypothalamic and other diencephalic structures, and HYPOPITUITARISM.

Also Known As: De Morsier Syndrome; Septo-Optic Dysplasia with Growth Hormone Deficiency; Dysplasia, Septooptic; Dysplasias, Septooptic; Morsier Syndrome, De; Septo Optic Dysplasia with Growth Hormone Deficiency; Septooptic Dysplasias; Syndrome, De Morsier; Septooptic Dysplasia

Networked: 74 relevant articles (0 outcomes, 3 trials/studies) for this Disease

Key Drugs and Agents for Septo-Optic Dysplasia

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:

Hormones : 1 study in 22 results : IBA
Growth Hormone (Somatotropin) : 1 study in 21 results : IBA
Melatonin : 1 study in 2 results : IBA
Transcription Factors (Transcription Factor) : 6 results : IBA
Absence of septum pellucidum : 5 results : IBA
Adrenocorticotropic Hormone (ACTH) : 4 results : FDA 7
Retinaldehyde (Retinal) : 3 results : IBA
Pituitary Hormones : 3 results : IBA
Thyrotropin (Thyroid-Stimulating Hormone) : 2 results : FDA 1
Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone) : 2 results : IBA

Show All >>

Diseases Related to Septo-Optic Dysplasia

Show All >>

Key Therapies for Septo-Optic Dysplasia

Efficacy Chart >>